Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Reducing Dupilumab Dose for Patients with Controlled Atopic Eczema
The NetherlandsStudy on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes
SpainStudy of Orismilast for Treating Moderate to Severe Ulcerative Colitis in Adults
DenmarkStudy on Tadekinig Alfa for Patients with NLRC4 Mutation and XIAP Deficiency
GermanyStudy on Long-Term Safety and Efficacy of Gene Therapy for Leukocyte Adhesion Deficiency-I Using RP-L201 in Patients with LAD-I
SpainStudy on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn's Disease
The NetherlandsStudy on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients
FranceStudy on the Effects of Modified-Release Hydrocortisone vs. Immediate-Release Hydrocortisone for Patients with Addison's Disease
IrelandStudy on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7
FranceStudy of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
GermanyStudy on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis
BelgiumStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
